Bracing for a Run of Major Patent Expirations
Executive Summary
More than $20 billion of branded drugs are scheduled to lose patent protection over the next four years, which translates into a $5 billion opportunity for generic drug makers, according to Cowen & Co. Following is a chart of major drug patent/ exclusivity expirations 2000-2001